ReP USP - Resultado da busca

Artigo de periodico
Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-'alfa', IL-1'beta' and CXCL1/KC (2012)
Guerrero, Ana T. G.; Cunha, Thiago Mattar; Verri Júnior, Waldiceu Aparecido; Guazzinelli, Ricardo T.; Teixeira, Mauro M.; Cunha, Fernando de Queiroz; Ferreira, Sérgio Henrique
Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: ARTICULAÇÕES, DOR, ARTRITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRERO, Ana T. G. et al. Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-'alfa', IL-1'beta' and CXCL1/KC. European Journal of Pharmacology, v. 674, n. 1, p. 51-57, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2011.10.023. Acesso em: 01 set. 2024.
APA
Guerrero, A. T. G., Cunha, T. M., Verri Júnior, W. A., Guazzinelli, R. T., Teixeira, M. M., Cunha, F. de Q., & Ferreira, S. H. (2012). Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-'alfa', IL-1'beta' and CXCL1/KC. European Journal of Pharmacology, 674( 1), 51-57. doi:10.1016/j.ejphar.2011.10.023
NLM
Guerrero ATG, Cunha TM, Verri Júnior WA, Guazzinelli RT, Teixeira MM, Cunha F de Q, Ferreira SH. Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-'alfa', IL-1'beta' and CXCL1/KC [Internet]. European Journal of Pharmacology. 2012 ; 674( 1): 51-57.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2011.10.023
Vancouver
Guerrero ATG, Cunha TM, Verri Júnior WA, Guazzinelli RT, Teixeira MM, Cunha F de Q, Ferreira SH. Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-'alfa', IL-1'beta' and CXCL1/KC [Internet]. European Journal of Pharmacology. 2012 ; 674( 1): 51-57.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2011.10.023
Artigo de periodico
Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury (2007)
Pompermayer, Kenia; Amaral, Flávio A.; Fagundes, Caio T.; Vieira, Angelica T.; Cunha, Fernando de Queiroz; Teixeira, Mauro M.; Souza, Danielle G.
Source: European Journal of Pharmacology. Unidade: FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POMPERMAYER, Kenia et al. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. European Journal of Pharmacology, v. 556, n. 1-3, p. 215-222, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2006.10.065. Acesso em: 01 set. 2024.
APA
Pompermayer, K., Amaral, F. A., Fagundes, C. T., Vieira, A. T., Cunha, F. de Q., Teixeira, M. M., & Souza, D. G. (2007). Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. European Journal of Pharmacology, 556( 1-3), 215-222. doi:10.1016/j.ejphar.2006.10.065
NLM
Pompermayer K, Amaral FA, Fagundes CT, Vieira AT, Cunha F de Q, Teixeira MM, Souza DG. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury [Internet]. European Journal of Pharmacology. 2007 ; 556( 1-3): 215-222.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2006.10.065
Vancouver
Pompermayer K, Amaral FA, Fagundes CT, Vieira AT, Cunha F de Q, Teixeira MM, Souza DG. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury [Internet]. European Journal of Pharmacology. 2007 ; 556( 1-3): 215-222.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2006.10.065
Artigo de periodico
Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis (2000)
Francischi, Janetti Nogueira de; Yokoro, Celina M.; Poole, Steve; Tafuri, Wagner L.; Cunha, Fernando de Queiroz; Teixeira, Mauro M.
Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: ARTRITES, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCISCHI, Janetti Nogueira de et al. Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. European Journal of Pharmacology, v. 399, p. 243-249, 2000Tradução . . Disponível em: https://doi.org/10.1016/s0014-2999(00)00330-7. Acesso em: 01 set. 2024.
APA
Francischi, J. N. de, Yokoro, C. M., Poole, S., Tafuri, W. L., Cunha, F. de Q., & Teixeira, M. M. (2000). Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. European Journal of Pharmacology, 399, 243-249. doi:10.1016/s0014-2999(00)00330-7
NLM
Francischi JN de, Yokoro CM, Poole S, Tafuri WL, Cunha F de Q, Teixeira MM. Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis [Internet]. European Journal of Pharmacology. 2000 ; 399 243-249.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/s0014-2999(00)00330-7
Vancouver
Francischi JN de, Yokoro CM, Poole S, Tafuri WL, Cunha F de Q, Teixeira MM. Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis [Internet]. European Journal of Pharmacology. 2000 ; 399 243-249.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/s0014-2999(00)00330-7

USP Schools

ReP

Filtros

Authors

Indexado em